US Grants.gov · Ouvert

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Page officielle de l'appel ↗

The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.

Historique des changements

First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.

  • 22 Oct 2026 · 1df80d0a3635
  • 22 Oct 2026 · 5cd090d8bf17
  • 21 Oct 2026 · 87406394c6a6
  • 20 Oct 2026 · 58df86eefc7d
  • 19 Oct 2026 · 93880d763e04
  • 18 Oct 2026 · bd2798370dc1
  • 17 Oct 2026 · d3d7da9577ab
  • 16 Oct 2026 · 34aa49356283
  • 15 Oct 2026 · c989a0b63d98
  • 14 Oct 2026 · 3aeeb4e9dfc2
  • 13 Oct 2026 · a3ba41855d81
  • 12 Oct 2026 · 0e22314dfd95
  • 11 Oct 2026 · e992f5aeae17
  • 10 Oct 2026 · 5cd108f49038
  • 09 Oct 2026 · 68ef067938e1
  • 08 Oct 2026 · 7de4404a3f3b
  • 07 Oct 2026 · c75680ed621c
  • 06 Oct 2026 · 8bb6b9dbc0bb
  • 05 Oct 2026 · d7120acd7f7c
  • 04 Oct 2026 · 17b601b0b82d

Report a problem with this record · How data is produced